Dirty production of NHS drugs fuelling rise of superbugs, says BIJ

Michele Maatouk Sharecast | 19 Oct, 2016 12:11 - Updated: 12:35 | | |

pills tablets medicine drugs pharmaceutical

Dirty production methods at pharmaceutical plants in India that are supplying the NHS with drugs are fuelling the rise of superbugs, according to the Bureau of Investigative Journalism (BIJ).

The BIJ said that tests on water samples taken outside pharmaceutical factories in India which sell to the NHS found they contained bacteria resistant to the antibiotics made inside the plants. This suggests industrial waste containing active antibiotic ingredients is being leaked into the surrounding environment, which studies have shown causes nearby bacteria to develop immunity to the drugs, creating superbugs.

There are currently no checks or regulations in place about the disposal of waste from the production process and the BIJ has found that companies with a history of bad practice and pollution are supplying the NHS, with environmental standards not a feature of NHS procurement protocols.

Pressure group Changing Markets, which campaigns on antimicrobial resistance, tested water samples collected at 36 locations across India – including sites adjacent to drug manufacturing plants as well as rivers and wastewater treatment plants – and found 16 contained antibiotic resistant E.coli bacteria.

The highest level of drug resistant bacteria was found in water samples from a factory run by multinational drug group Aurobindo Pharma, which has supplied antibiotics to NHS trusts across England in the last three years through its UK subsidiary.

Aurobindo also has a £450,000-a-year contract supplying every NHS health region in Scotland with antibiotics such as flucloxacillin, metronidazole and meropenem.

Economist Jim O’Neill, who carried out a major review into antibiotic resistance, told the BIJ the results of the tests were “deeply troubling”.

His study, which was commissioned by the UK government, found that superbugs would kill more people than cancer by 2050 if no action is taken, and cited pollution in pharmaceutical supply chains as a major problem.

The BIJ said on Wednesday that at least three companies licensed to supply the NHS have not signed up to a new roadmap put in place following a recent United Nations antibiotic resistance summit, in which 13 global pharmaceutical firms pledged to review manufacturing and supply chains to make sure the release of antibiotics into the environment was being properly controlled.

In response to the BIJ’s findings, the Department of Health said it would consider bringing in new rules for antibiotic factories which export drugs to the UK.

More news

09:02 Randgold Resources to extend life of Ivory Coast gold mine

Randgold Resources is seeking to extend the operation life of its Tongon gold mine in the Côte d'lvoire beyond its four-year lifespan.

08:00 Interserve wins £36.5m contract to build school in South Wales

Support services and construction group Interserve has won a £36.5m contract to design and build a new secondary school in Caldicot, South Wales.

07:56 Jimmy Choo announces strategic review, puts itself up for sale

Jimmy Choo said on Monday that it is conducting a review of various strategic options to "maximise value for its shareholders", including the sale of the company.

07:47 Camden Town owner bought out by gambling billionaire founder

The owner of Camden Market in London, Market Tech Holdings, agreed on Friday evening to be taken over by Israeli billionaire Teddy Sagi's LabTech Investments for almost £900m, with the shares down 35% since floating two and a half years ago.

07:46 Mortice to buy property services company Elite for up to £4.5m

AIM-listed securities and facilities management company Mortice and its wholly-owned subsidiary Tenon have agreed to pay up to £4.5m for Manchester-based property services group Elite in cash and shares.

08:02 French equity futures jump after election result, analysts divided

Equity futures were pointing to a sharply higher open for French stocks after centrist Emanuelle Macron was revealed to have won the first round of voting in the country's presidential elections at the weekend.

07:40 Tritax Big Box REIT to raise £200m to fund investment opportunities

Tritax Big Box Real Estate Investment Trust is to raise £200m in equity in order to capitilise on property investment opportunities.

07:39 Goals Soccer and Powerleague in preliminary talks

Goals Soccer Centres said it was in early-stage talks with Powerleague, but this was "but one of the strategic opportunities currently being assessed".

07:39 Anglo American on target as diamonds and iron balance copper drop

Copper production fell in the first quarter at Anglo American, but full year guidance was kept unchanged across the board as amounts of iron ore, coal and diamonds unearthed all rose strongly.

07:29 London pre-open: Stocks seen higher as investors eye French election

London stocks were set for a positive open on Monday as investors digested the first round of the French presidential elections.